NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 344 filers reported holding NATERA INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,069,689 | -49.7% | 9,878 | -57.5% | 0.05% | -48.5% |
| Q1 2024 | $2,127,543 | +166.9% | 23,262 | +82.8% | 0.10% | +86.8% |
| Q4 2023 | $797,094 | -65.1% | 12,725 | -75.3% | 0.05% | -53.1% |
| Q3 2023 | $2,281,928 | -55.8% | 51,569 | -56.2% | 0.11% | -47.7% |
| Q3 2022 | $5,159,000 | +447.1% | 117,735 | +342.6% | 0.22% | +440.0% |
| Q2 2022 | $943,000 | -75.9% | 26,600 | -72.3% | 0.04% | -72.6% |
| Q1 2022 | $3,913,000 | -51.0% | 96,185 | +12.5% | 0.15% | -58.4% |
| Q4 2021 | $7,983,000 | -19.1% | 85,481 | -3.4% | 0.35% | -27.3% |
| Q3 2021 | $9,865,000 | +6.5% | 88,525 | +8.5% | 0.48% | +11.5% |
| Q2 2021 | $9,261,000 | +88.3% | 81,576 | +68.4% | 0.43% | +43.9% |
| Q1 2021 | $4,918,000 | +394.3% | 48,433 | +384.3% | 0.30% | +271.6% |
| Q4 2020 | $995,000 | -75.0% | 10,000 | -81.8% | 0.08% | -76.8% |
| Q3 2020 | $3,979,000 | +103.3% | 55,087 | +40.4% | 0.35% | +55.1% |
| Q2 2020 | $1,957,000 | – | 39,249 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |